Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Notorious Short-Seller Goes Long Sunedison and You Should Follow Him

Page 1 of 2

John Hempton’s Bronte Capital is long Sunedison Inc (NYSE:SUNE). Hempton is a famous short seller, so when he goes long on a stock, it gets people’s attention. Hempton is also a bit of a contrarian. He went long Herbalife Ltd (NYSE:HLF) in 2013, after Bill Ackman shorted it and the investing public sold the stock. By going long SunEdison, Hempton is once again going against the crowd. SunEdison shares are down 63% year-to-date and off 78% from their peak this year as investors fret over the company’s liquidity. Let’s take a closer look at Hempton’s thesis. 

SunEdison SUNE Solar Panels

We pay attention to hedge funds’ moves because our research has shown that hedge funds are extremely talented at picking stocks on the long side of their portfolios. It is true that hedge fund investors have been underperforming the market in recent years. However, this was mainly because hedge funds’ short stock picks lost a ton of money during the bull market that started in March 2009. Hedge fund investors also paid an arm and a leg for the services that they received. We have been tracking the performance of hedge funds’ 15 most popular small-cap stock picks in real time since the end of August 2012. These stocks have returned 118% since then and outperformed the S&P 500 Index by around 60 percentage points (see more details here). That’s why we believe it is important to pay attention to hedge fund sentiment; we also don’t like paying huge fees.

Follow Sunedison Inc. (NYSE:SUNEQ)
Trade (NYSE:SUNEQ) Now!

In his blog entry on the solar firm, Hempton acknowledged that Sunedison Inc (NYSE:SUNE) is a ‘trust me’ stock, as the company’s balance sheet has many related parties ‘and the copious amounts of different types of debt these companies have [are] complex and even scary accounts’.

Given his accounting background, however, Hempton is uniquely suited for ‘getting to the bottom of complex accounts’ and properly evaluating the fair value of the obscure securities.

Hempton thinks Sunedison’s existing projects are worth a lot. He also thinks that the Sunedison has enormous value if it repairs its relationship with the capital markets.

“Any solar farm deal you put in place 3-5 years ago has worked out. Both solar panel prices and interest rates are lower than you would have baked into your cash flow models. We would be enormously surprised if the past deals of Sun Edison did not work out. Whether the future deals work out is however an open question. Low solar panel prices and low interest rates are not exactly a secret – and the funding cost for solar panel farms has risen with this panic. Bluntly we think unless the company repairs its relationship with capital markets it is unlikely to be able to generate good deals in the future and it will wind up in run-off.”

When it comes to the market’s concern over Sunedison’s liquidity, Hempton thinks investors are being irrational. Based on the information gathered from industry experts, Hempton reaches the conclusion that:

“Specifically all construction finance automatically can be termed out as project finance (over the life of the project and linked to the project) when the construction is done. If this is true the market fear for this company cannot cause insolvency. Given that the company is priced as if insolvency is likely this stock should produce a good return from here.”

Although Hempton can’t see all of Sunedison’s funding and thus can’t be completely sure that Sunedison won’t go bankrupt, he has seen a great deal and thinks the stock is a good bet.

“Now of course we have not seen and understood all of the finance deals. Only the ones we can find. But that is sufficient to know we are probably right. And that is the case for buying. The old projects are good and they should run off at an attractive clip.”

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!